iCancer is inviting applications for editorial board members
The journal is building an international editorial team across clinical oncology, cancer biology, translational research, biomedical data science, and cancer health services.
Why publish in iCancer?
iCancer publishes rigorous open-access oncology research across discovery biology, translational medicine, clinical oncology, precision medicine, artificial intelligence, epidemiology, and cancer care delivery.
Call for papers
iCancer welcomes original research, reviews, systematic reviews, brief reports, perspectives, methods, and resources that advance cancer research or clinical oncology practice.
Editorial Board Member applications
Articles
Early ViewReal-World Safety Landscape and Prognostic Risk Stratification of Adverse Events in Bispecific T-Cell Engagers
Published online:
Bispecific T-cell engagers (BiTEs) are pivotal for hematological malignancies. However, real-world safety assessments often emphasize adverse event (AE) incidence while overlooking severity and fatality rates.
This article: Open access under CC BY-ND 4.0.
Recent issues
All issues
Inaugural issue in preparation
The first issue cover frames the tumor immune microenvironment as a disease fortress, connecting immune regulation, integrative multi-omics analysis, and precision oncology.